Edition:
United Kingdom

People: Abcam PLC (ABCA.L)

ABCA.L on London Stock Exchange

1,207.00GBp
16 Aug 2019
Change (% chg)

1.00 (+0.08%)
Prev Close
1,206.00
Open
1,224.00
Day's High
1,224.00
Day's Low
1,197.00
Volume
143,509
Avg. Vol
352,038
52-wk High
1,643.80
52-wk Low
1,006.00

Milner, Jonathan 

Dr. Jonathan Simon Milner, Ph.D. is Non-Executive Deputy Chairman of the Board of Abcam Plc. Having worked in the life sciences industry for over ten years as an academic researcher, Jonathan identified the market opportunity for supplying high-quality antibodies to support protein interaction studies and in 1998 founded Abcam with Dr David Cleevely and Professor Tony Kouzarides. Jonathan is a Non-Executive Director of The Evolution Education Trust, HealX, Repositive Ltd, Syndicate Room Group Ltd and Elpis Biomedical Ltd. He is also Chairman of Axol Bioscience Ltd, PhoreMost Ltd and CamAllergy Ltd. Jonathan holds an Executive Director position at Meltwind Limited, being a designated member of Meltwind Advisory LLP, and is a member of the advisory panel of Cambridge Innovation Capital plc. Jonathan is an experienced entrepreneur and investor and is passionate about supporting UK life science and high-tech start-ups. He has provided considerable investment and support to over 40 companies and has assisted three AIM IPOs.

Basic Compensation

Total Annual Compensation, GBP 70,000
Restricted Stock Award, GBP --
Long-Term Incentive Plans, GBP --
All Other, GBP --
Fiscal Year Total, GBP 70,000

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Peter Allen

9,000

Alan Hirzel

1,788,000

Jonathan Milner

70,000

Gavin Wood

666,000

Marc Perkins

--

Giles Kerr

--
As Of  30 Jun 2018